Delivery Order SPE2DB20D2002-SPE2DB26FK97Y
Award Date 10/20/25
Potential Completion Date 10/21/25
Potential Value $58K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,342.46 for Boostrix TDAP vaccine in 0.5mL syringe format on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,064.40 for Boostrix TDAP vaccine in 0.5ml syringes, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's critical role in supporting federal medical procurement, particularly for...
- The Defense Logistics Agency awarded a delivery order valued at $52,873.75 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $3,696.56, for Boostrix TDAP vaccine in 0.5mL syringe format. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of July 18, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance...
- The Defense Logistics Agency awarded a $145,533.40 delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by September 15, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's competitive capability to meet federal procurement standards. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) with a contract ceiling value of $7,909.80. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $133,843.21 on August 12, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award. Performance will be conducted at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is executed under...
- The Defense Logistics Agency awarded a $40,162 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Boostrix Tdap vaccine in 0.5ml syringe format, with an ultimate completion date of October 17, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract specifies performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $20,469.02 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order is scheduled for completion by September 18, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a ceiling value of $14,722.52. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside procurement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as...